About Prof. Xu Zhengmin
Prof. Xu Zhengmin (许政敏) is Chief Physician, Professor, Doctoral Supervisor, and one of China's foremost authorities on pediatric otolaryngology, childhood hearing loss, and cochlear implant surgery, based at Xinhua Hospital, Shanghai Jiao Tong University School of Medicine — one of China's premier academic medical centers and a nationally recognized center of excellence in pediatric medicine, otolaryngology, and audiology. Prof. Xu has dedicated his career to the diagnosis, surgical management, and audiological rehabilitation of children with hearing loss — one of the most prevalent and consequential congenital and acquired disabilities in childhood — and has built one of China's largest and most experienced pediatric cochlear implant programs, having performed thousands of cochlear implant surgeries and overseen the audiological rehabilitation of hundreds of children who have gone on to develop spoken language and integrate into mainstream education.
Childhood hearing loss, if undetected or untreated, leads to profound and irreversible delays in speech and language development, cognitive development, and social integration. The window for optimal cochlear implantation — ideally before 12 months of age for children with congenital profound sensorineural hearing loss — is narrow, and the outcomes of cochlear implantation are highly dependent on the surgical expertise of the implanting surgeon, the quality of the audiological mapping and rehabilitation program, and the integration of the multidisciplinary team. Prof. Xu's program at Xinhua Hospital is recognized nationally as a model for the comprehensive, multidisciplinary management of childhood hearing loss, from newborn hearing screening and early diagnosis through surgical implantation and long-term audiological and speech-language rehabilitation.
Prof. Xu's clinical expertise extends beyond cochlear implantation to encompass the full spectrum of pediatric otolaryngology, including chronic otitis media, cholesteatoma, congenital ear malformations, auditory neuropathy spectrum disorder (ANSD), and hearing loss in children with complex medical backgrounds including inner ear malformations, cochlear nerve deficiency, and syndromic hearing loss. He also maintains expertise in adult cochlear implantation and auditory brainstem implantation (ABI) for patients with cochlear nerve aplasia or neurofibromatosis type 2.
Hospital Affiliation: Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
Xinhua Hospital (新华医院), affiliated with Shanghai Jiao Tong University School of Medicine, is one of Shanghai's largest and most respected academic medical centers and a national leader in pediatric medicine, neonatology, congenital heart disease, and otolaryngology. The Department of Otolaryngology-Head and Neck Surgery at Xinhua Hospital is a national key clinical specialty, and its pediatric cochlear implant program is one of the most active and experienced in China, performing a high volume of cochlear implant surgeries annually across all age groups from infants to adults.
The hospital's cochlear implant program is supported by a dedicated audiology center with state-of-the-art diagnostic equipment including auditory brainstem response (ABR) testing, auditory steady-state response (ASSR), otoacoustic emissions (OAE), high-resolution CT and MRI of the temporal bone, and a full cochlear implant mapping and programming service. The program integrates otolaryngology, audiology, speech-language pathology, pediatric neurology, genetics, and special education to deliver comprehensive, multidisciplinary care for children with hearing loss. Xinhua Hospital's cochlear implant program is consistently recognized as one of the top programs in China and has been a national training center for cochlear implant surgery and audiology.
Clinical Expertise
- Cochlear implantation in children — bilateral profound sensorineural hearing loss; cochlear implantation in infants under 12 months; simultaneous bilateral cochlear implantation; sequential bilateral cochlear implantation; cochlear implantation in children with inner ear malformations (common cavity, incomplete partition types I-III, enlarged vestibular aqueduct); cochlear implantation in children with cochlear nerve deficiency; cochlear implantation in children with auditory neuropathy spectrum disorder (ANSD); revision cochlear implant surgery; device explantation and reimplantation
- Cochlear implantation in adults — post-lingual deafness; pre-lingual deafness in adults; cochlear implantation after meningitis-related ossification; cochlear implantation in elderly patients; hybrid cochlear implantation (electric-acoustic stimulation) for patients with residual low-frequency hearing
- Auditory brainstem implantation (ABI) — cochlear nerve aplasia; neurofibromatosis type 2 (NF2); post-acoustic neuroma resection; patients not suitable for cochlear implantation due to absent cochlear nerve
- Newborn hearing screening and early intervention — interpretation of failed newborn hearing screening results; diagnostic ABR and ASSR in infants; early diagnosis of congenital hearing loss; genetic counseling coordination for hereditary hearing loss; early fitting of hearing aids; counseling for families on cochlear implant candidacy and timing
- Chronic otitis media and cholesteatoma — tympanoplasty; mastoidectomy; canal wall up and canal wall down procedures; ossicular chain reconstruction; management of cholesteatoma in children; combined approach tympanoplasty; management of complications of chronic otitis media including labyrinthitis and facial nerve involvement
- Congenital ear malformations — congenital aural atresia; microtia with atresia; bone-anchored hearing aids (BAHA) and active transcutaneous bone conduction implants (Osia, Bonebridge) for atresia; surgical atresia repair for appropriate candidates; coordination with plastic surgery for auricular reconstruction
- Syndromic hearing loss — Waardenburg syndrome; Usher syndrome; Pendred syndrome; CHARGE syndrome; Down syndrome with hearing loss; Treacher Collins syndrome; evaluation and management of hearing loss in the context of complex syndromic diagnoses; coordination with genetics and pediatric subspecialties
- Audiological rehabilitation — cochlear implant mapping and programming; hearing aid fitting and optimization; auditory verbal therapy (AVT) coordination; speech-language pathology referral and coordination; school integration support; long-term audiological follow-up
- Expert second opinion — review of audiological test results, temporal bone imaging, and cochlear implant candidacy assessment for children and adults with hearing loss who are seeking a second opinion on cochlear implant candidacy, surgical approach, or device selection; written English-language second opinion reports available through CMCS
Academic Leadership & Research Contributions
Prof. Xu Zhengmin is one of China's most prolific and influential researchers in pediatric otolaryngology and cochlear implantation. He has authored and co-authored more than 200 peer-reviewed publications in Chinese and international journals, including contributions to Otology & Neurotology, Cochlear Implants International, International Journal of Pediatric Otorhinolaryngology, Hearing Research, and Chinese Medical Journal. His research has focused on the outcomes of early cochlear implantation in infants with congenital profound hearing loss, the surgical management of cochlear implantation in children with inner ear malformations, the audiological and speech-language outcomes of bilateral cochlear implantation, the genetics of hereditary hearing loss in Chinese populations, and the development of novel surgical techniques for cochlear implantation in anatomically challenging cases.
Prof. Xu has served on the editorial boards of Chinese otolaryngology and audiology journals and has been a principal investigator on national research grants from the National Natural Science Foundation of China (NSFC) and the Shanghai Municipal Health Commission. He is a standing committee member of the Otolaryngology Group of the Chinese Medical Association (CMA) and the Cochlear Implant Professional Committee of the Chinese Association of Rehabilitation of Disabled Persons (CARDP), and has been an invited lecturer at the Chinese Otolaryngology-Head and Neck Surgery Society annual congress, the Asia Pacific Symposium on Cochlear Implants and Related Sciences (APSCI), the European Symposium on Paediatric Cochlear Implantation (ESPCI), and international cochlear implant workshops. He has trained numerous otolaryngology fellows with a focus on cochlear implantation and pediatric otology and is recognized as one of the leading educators in this field in China.
Prof. Xu has also been involved in the development of Chinese national consensus guidelines for newborn hearing screening, cochlear implant candidacy assessment, and cochlear implant rehabilitation, and has contributed to the introduction of new cochlear implant devices and surgical techniques into China, working with international manufacturers and academic centers to evaluate and adapt new technologies for the Chinese patient population. His program at Xinhua Hospital has been a national demonstration center for the comprehensive management of childhood hearing loss and has influenced the development of cochlear implant programs at hospitals across China.
Why International Patients Choose Prof. Xu Zhengmin
For international families with a child diagnosed with profound sensorineural hearing loss — whether identified through newborn hearing screening, developmental surveillance, or following meningitis or other acquired causes — the decision about cochlear implantation is one of the most important and time-sensitive they will face. The outcomes of cochlear implantation are highly dependent on the age at implantation, the surgical expertise of the implanting surgeon, the quality of the audiological mapping program, and the intensity and quality of post-implant auditory verbal rehabilitation. Prof. Xu's program at Xinhua Hospital offers all of these elements at a level of quality and experience that is genuinely world-class.
Many international families arrive at CMCS seeking a second opinion on cochlear implant candidacy — particularly for children with inner ear malformations, cochlear nerve deficiency, or auditory neuropathy spectrum disorder, where cochlear implant candidacy is less straightforward and the expected outcomes are more variable. Prof. Xu's expertise in cochlear implantation in anatomically and physiologically complex cases, and his ability to provide a clear, evidence-based assessment of candidacy, expected outcomes, and the optimal surgical approach, is of particular value to families navigating these difficult decisions.
For families from countries where cochlear implantation is subject to long waiting lists — particularly in public healthcare systems in the United Kingdom, Canada, Australia, and parts of Europe — the ability to access cochlear implant surgery at Xinhua Hospital within weeks rather than months or years can be decisive for a child's language development outcomes, given the critical importance of early implantation. Treatment costs for cochlear implantation at Xinhua Hospital, including the implant device, surgery, hospitalization, and initial mapping, are substantially lower than equivalent procedures in Western healthcare systems, and CMCS can coordinate the entire process from initial consultation through surgery and post-operative mapping for international families.
For adult patients with post-lingual deafness who are seeking cochlear implantation, Prof. Xu's program offers rapid access to candidacy assessment, surgery, and mapping, with outcomes comparable to the world's leading cochlear implant centers. CMCS has coordinated cochlear implant consultations and surgeries for patients and families from North America, Europe, Southeast Asia, and the Middle East through Prof. Xu's team at Xinhua Hospital.
What to Expect at Your Consultation
Consultations with Prof. Xu begin with a comprehensive review of all prior audiological test results — including newborn hearing screening results, diagnostic ABR and ASSR, pure tone audiogram (for older children and adults), speech perception testing, otoacoustic emissions, and tympanometry — as well as high-resolution CT and MRI of the temporal bones, genetic testing results if available, and the patient's medical history including any history of meningitis, ototoxic medication exposure, or syndromic diagnosis. CMCS will arrange certified translation of all medical records, audiological reports, and imaging reports in advance of the consultation.
Prof. Xu will assess cochlear implant candidacy, evaluate the anatomy of the cochlea and cochlear nerve on imaging, outline the recommended surgical approach and device selection with detailed rationale, discuss the expected audiological and speech-language outcomes, and provide a clear plan for post-implant mapping and rehabilitation. For children with complex medical backgrounds or syndromic diagnoses, a multidisciplinary assessment involving pediatric neurology, genetics, and speech-language pathology will be coordinated as appropriate. A written English-language consultation summary — including audiological assessment, imaging interpretation, candidacy determination, recommended treatment plan, and rehabilitation protocol — is provided after every appointment, and CMCS will facilitate direct communication between Prof. Xu's team and the patient's home audiologist and otolaryngologist for continuity of care planning.
Book a Consultation Through CMCS
China Medical Concierge Shanghai (CMCS) provides comprehensive end-to-end support for international patients and families seeking pediatric hearing loss consultation or cochlear implant surgery with Prof. Xu Zhengmin at Xinhua Hospital. Our services include priority consultation scheduling with Prof. Xu's team and the multidisciplinary audiology team, certified medical record and audiological report translation, pre-consultation audiological and imaging review by our clinical coordinators, surgical logistics and hospital admission coordination, visa and travel support for families traveling with a child, accommodation recommendations near Xinhua Hospital, on-site interpretation throughout the consultation, surgery, and post-operative mapping appointments, device and pharmacy coordination, and ongoing follow-up coordination between Prof. Xu's team and the patient's home audiologist and physicians after return.
0 comentarios